Site Loader
Rua Rio Grande do Sul 1, Santos-SP

Last year, the anti-inflammatory drug generated more than 22% of Amgen's total revenue. Based on earnings estimates, Amgen will have a dividend payout ratio of 37.65% next year. 75.23% of the stock of Amgen is held by institutions. AMGN Stock Summary Amgen Inc's market capitalization of $133,852,207,271 is ahead of 98.5% of US-listed equities. Please log in to your account or sign up in order to add this asset to your watchlist. The medical research company earns $7.84 billion in net income (profit) each year or $14.82 on an earnings per share basis. PEG Ratios above 1 indicate that a company could be overvalued. Get today's Amgen Inc stock price and latest AMGN news as well as Amgen real-time stock quotes, technical analysis, full financials and more. Omecamtiv mecarbil, an investigational selective cardiac myosin activator, was studied in GALACTIC … On the stock market today, Amgen stock jumped 2.8% to 241.60. Vote “Underperform” if you believe AMGN will underperform the S&P 500 over the long term. Amgen employs 23,400 workers across the globe. Amgen’s Commitment to Patients Our Approach to Pricing, Access and Affordability Access Approaches, Treatments, and Collaborations On Dec. 5, Amgen (AMGN) said 83% of multiple myeloma patients responded to its experimental drug in a … The company issued revenue guidance of $25.1-25.5 billion, compared to the consensus revenue estimate of $25.39 billion. View our earnings forecast for Amgen. The medical research company had revenue of $6.42 billion for the quarter, compared to analyst estimates of $6.38 billion. Find the latest news headlines from Amgen Inc. Common Stock (AMGN) at Nasdaq.com. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Amgen Inc. Common Stock (AMGN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. AMGN | Complete Amgen Inc. stock news by MarketWatch. All rights reserved. Interested parties can register for or listen to the call using this link or dial in at Not Available. The consensus among Wall Street equities research analysts is that investors should "buy" Amgen stock. There are currently 1 sell rating, 12 hold ratings and 17 buy ratings for the stock. (Add your “outperform” vote. Amgen pays a meaningful dividend of 2.69%, higher than the bottom 25% of all stocks that pay dividends. Amgen issued an update on its FY20 earnings guidance on Wednesday, October, 28th. The company's average rating score is 2.53, and is based on 17 buy ratings, 12 hold ratings, and 1 sell rating. Amgen’s value is below its 50-day moving average of $228.10 and below its 200-day moving average of $238.25. Media stories about AMGN stock have trended somewhat positive on Sunday, InfoTrie Sentiment Analysis reports. Amgen has a PEG Ratio of 1.84. Based on earnings estimates, Amgen will have a dividend payout ratio of 37.65% next year. Stockholders of record on Monday, February 15th will be paid a dividend of $1.76 per share on Monday, March 8th. THOUSAND OAKS, Calif., Nov. 23, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Company has provided notice to Cytokinetics of termination of its collaboration and its intention to transition the development and commercialization rights for omecamtiv mecarbil and AMG 594. Amgen has only been increasing its dividend for 1 years. AMGN stock was sold by a variety of institutional investors in the last quarter, including RNC Capital Management LLC, State of Alaska Department of Revenue, American National Bank, Pinnacle Financial Partners Inc., Huntington National Bank, Baldwin Brothers Inc. MA, Cullinan Associates Inc., and Douglas Lane & Associates LLC. The medical research company reported $4.37 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $3.75 by $0.62. The Amgen Inc. stock price gained 1.65% on the last trading day (Thursday, 14th Jan 2021), rising from $237.74 to $241.66. Amgen Submits Sotorasib New Drug Application To U.S. FDA For Advanced Or Metastatic Non-Small Cell Lung Cancer With KRAS G12C Mutation By PR Newswire Dec 16, 2020 4:00 PM EST This list is generated from recent searches, followed securities, and other activity. Amgen has been the subject of 16 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Wall Street analysts have given Amgen a "Buy" rating, but there may be better short-term opportunities in the market. Amgen has received 59.92% “outperform” votes from our community. Amgen’s Moving Average. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA. Amgen will be holding an earnings conference call on Tuesday, February 2nd at 12:00 AM Eastern. The dividend payout ratio of Amgen is 43.18%. View today's stock price, news and analysis for Amgen Inc. (AMGN). View analysts' price targets for Amgen or view Wall Street analyst' top-rated stocks. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology. Follow AMGN. The medical research company can be reached via phone at 805-447-1000 or via email at [email protected]. The worst news of all for Amgen is that sales are falling for its top-selling drug, Enbrel. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Find the latest Amgen Inc. (AMGN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Amgen had a net margin of 29.42% and a return on equity of 95.55%. In terms of volatility of its share price, AMGN is more volatile than merely 1.87% of stocks … Vote “Outperform” if you believe AMGN will outperform the S&P 500 over the long term. Find the latest AMGN stock analysis. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock, A score provided by CDP (formerly the Carbon Disclosure Project) that rates a company on its climate transparency and performance. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. What’s Ahead for the Stock. The ex-dividend date is Thursday, February 11th. The company provided EPS guidance of $15.80-16.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $15.78. They also gave headlines about the medical r… MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Amgen News . This indicates that Amgen will be able to sustain or increase its dividend. KushCo: A Cannabis Stock That Could be Fire, Defi Is The Next Generation For Cryptocurrency Investors, Village Farms International (NASDAQ: VFF) Stock is a Unique Cannabis ESG Play, Disney (NYSE:DIS) Shuts Down Annual Pass Program, But Still Consider Disney a Buy, Surprising Results Prove Little Help to PNC Financial (NYSE:PNC), Progress Software (NASDAQ:PRGS) Slips After Weak Guidance, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The Investor Relations website contains information about Amgen Inc.'s business for stockholders, potential investors, and financial analysts. A high-level overview of Amgen Inc. (AMGN) stock. Amgen’s stock is valued at $227.62 at 11:39 EST, way under its 52-week high of $264.97 and way above its 52-week low of $177.05. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Amgen has received 1,428 “outperform” votes. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. THOUSAND OAKS, Calif., Jan. 6, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 39th Annual J.P. Morgan Healthcare Conference at 11:50 a.m. PT on Monday, Jan. 11, 2021. Sign-up to receive the latest news and ratings for AMGN and its competitors with MarketBeat's FREE daily newsletter. Amgen's stock was trading at $198.65 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Green day on Thursday for Amgen Inc. (Updated on January 14, 2021) Buy candidate since 2021-01-08 Gain 1.33% PDF . Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Amgen latest news. The P/E ratio of Amgen is 19.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.99. Amgen's mailing address is ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA, 91320. To see all exchange delays and terms of use please see disclaimer. View Amgen's dividend history. . This suggests a possible upside of 4.1% from the stock's current price. Company insiders that own Amgen stock include Cynthia M Patton, David Piacquad, David W Meline, Jonathan P Graham, R Sanders Williams and Ronald D Sugar. Amgen has received a consensus rating of Buy. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. View our full suite of financial calendars and market data tables, all for free. The difference between the high and low prices over the past day, The difference between the high and low prices over the past 52 weeks. Delta Air Lines or Southwest Airlines: Which Is a Better Buy As Vaccines Roll Out? Amgen Inc. (NASDAQ:AMGN) announced its quarterly earnings results on Monday, November, 2nd. Get daily stock ideas top-performing Wall Street analysts. View insider buying and selling activity for Amgen or view top insider-selling stocks. Amgen has a P/B Ratio of 15.08. Learn everything you need to know about successful options trading with this three-part video course. Amgen’s stock has declined 5.2% this year so far against an increase of 9.2% for the industry. Specifically, they have bought $0.00 in company stock and sold $296,590.00 in company stock. View insider buying and selling activity for Amgen or or view top insider-buying stocks. View institutional ownership trends for Amgen. Amgen is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021. Explore commentary on Amgen Inc. and hear what the experts at … The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. View which stocks have been most impacted by COVID-19. Amgen pays an annual dividend of $6.40 per share and currently has a dividend yield of 2.69%. Identify stocks that meet your criteria using seven unique stock screeners. Stock analysis for Amgen Inc (AMGN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get short term trading ideas from the MarketBeat Idea Engine. Learn more. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Amgen's management team includes the following people: Sr. VP of Worldwide Compliance & Bus. © American Consumer News, LLC dba MarketBeat® 2010-2021. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The biotech company is heavily focused on developing a cancer drug known as sotorasib. Amgen (NASDAQ:AMGN) Stock Rating Lowered by BidaskClub marketbeat.com - August 8 at 8:10 AM: If You’ve Been Waiting, It’s Time To Buy AbbVie (NYSE: ABBV) (AMGN) marketbeat.com - August 3 at 2:08 PM: Amgen Stock (NASDAQ: AMGN) a Buy: Biotech Brilliance (AMGN) marketbeat.com - August 3 at … View the latest Amgen Inc. (AMGN) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get the latest Amgen Inc. (AMGN) stock news and headlines to help you in your trading and investing decisions. Fundamental company data provided by Morningstar and Zacks Investment Research. The official website for Amgen is www.amgen.com. Amgen trades on the NASDAQ under the ticker symbol "AMGN.". Amgen in Autoimmune Collaboration With EVOQ Therapeutics January 13 2021 - 07:26AM Dow Jones News ... Amgen (NASDAQ:AMGN) Historical Stock Chart From Dec 2020 to Jan 2021 Amgen (NASDAQ:AMGN) Historical Stock Chart Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Amgen's Thousand Oaks staff in 2017 numbered 5,125 and included hundreds of scientists, making Amgen the largest employer in Ventura County. Some companies that are related to Amgen include Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Alexion Pharmaceuticals (ALXN), Seagen (SGEN), Exact Sciences (EXAS), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS), Novavax (NVAX) and United Therapeutics (UTHR). Amgen is one of the world’s leading biotechnology companies. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; Adaptive Biotechnologies; and Eli Lilly and Company, as well as has a strategic agreement with McKesson Corporation to help improve cancer care in community oncology settings. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Real time Amgen (AMGN) stock price quote, stock graph, news & analysis. Their forecasts range from $185.00 to $304.00. Amgen's stock is owned by a number of retail and institutional investors. High institutional ownership can be a signal of strong market trust in this company. Looking for new stock ideas? Shares of AMGN can be purchased through any online brokerage account. Previous days news about Amgen. (Add your “underperform” vote.). Amgen earned a news sentiment score of 1.3 on InfoTrie's scale. Only 0.36% of the stock of Amgen is held by insiders. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. One share of AMGN stock can currently be purchased for approximately $245.49. Learn about financial terms, types of investments, trading strategies and more. Learn more. You may vote once every thirty days. This represents a $7.04 dividend on an annualized basis and a dividend yield of 2.87%. MarketBeat's community ratings are surveys of what our community members think about Amgen and other stocks. Cookies help us deliver our services. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Top institutional investors include Gateway Investment Advisers LLC (0.04%), Cullinan Associates Inc. (0.03%), Boston Trust Walden Corp (0.03%), State of Alaska Department of Revenue (0.02%), Wedge Capital Management L L P NC (0.02%) and Crossmark Global Holdings Inc. (0.02%). Since then, AMGN stock has increased by 23.6% and is now trading at $245.49. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. By using our services, you agree to our use of cookies. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Receive a free world-class investing education from MarketBeat. Amgen stock analysis based on the TipRanks smart score of 8 unique data sets and technical analysis. AMGN's went public 35.03 years ago, making it older than 92.92% of listed US stocks we're tracking. Amgen declared a quarterly dividend on Wednesday, December 16th. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Export data to Excel for your own analysis. Amgen sponsors the Tour of California. This indicates that Amgen will be able to sustain or increase its dividend. Amgen To Present At The 39th Annual J.P. Morgan Healthcare Conference 09:00pm, Wednesday, 06'th Jan 2021. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … View Amgen's earnings history. The dividend payout ratio of Amgen is 43.18%. View analyst ratings for Amgen or view MarketBeat's top 5 stock picks. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Amgen does not yet have a strock track record of dividend growth. Want to see which stocks are moving? 30 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Amgen in the last year. Amgen has a market capitalization of $142.92 billion and generates $23.36 billion in revenue each year. News Smart Portfolio Markets Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. Based on aggregate information from My MarketBeat watchlists, some companies that other Amgen investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Intel (INTC), Cisco Systems (CSCO), Pfizer (PFE), AbbVie (ABBV), The Walt Disney (DIS), AT&T (T), Alibaba Group (BABA) and The Home Depot (HD). A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. AMGN stock was bought by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., Chesley Taft & Associates LLC, Louisiana State Employees Retirement System, Oak Harvest Investment Services, Boston Trust Walden Corp, Wedge Capital Management L L P NC, Bennicas & Associates Inc., and Verity & Verity LLC. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. 236.59 0.00 (0.0%) Upgrade to Real-Time Premarket . Do Not Sell My Information. This payout ratio is at a healthy, sustainable level, below 75%. Amgen Inc. Stock News NASDAQ:AMGN. Amgen’s Competition Heated Up in 2020. On average, they anticipate Amgen's stock price to reach $255.52 in the next year. This is a positive change from Amgen's previous quarterly dividend of $1.60. 30 analysts have issued 12-month price targets for Amgen's shares. Ethics and Chief Compliance Officer, Start Your Risk-Free Trial Subscription Here, Nestlé recalls 762,000 pounds of pepperoni Hot Pockets, The Latest: Brazil 2nd in global deaths; no vaccines yet, Deaths, self-immolation draw scrutiny on China tech giants, GM to build electric delivery vans in Canada, The Latest: Pakistan approves Oxford-AstraZeneca vaccine, Extremists exploit a loophole in social moderation: Podcasts, Violent youth protests hit Tunisia amid economic turmoil, 3 Recession-Proof Dividend Stocks to Buy Now. Includes the following people: Sr. VP of worldwide Compliance & Bus and stock quotes for a financial... 43.18 % the market Amgen insiders have sold more of their company 's stock was at. This stock employer in Ventura County headlines from Amgen 's stock was trading at 198.65. S product sales to date on the stock is an American multinational biopharmaceutical headquartered! Our use of cookies decisions by providing real-time financial data and objective market analysis and headlines help... Total revenue through any online brokerage account able to sustain or increase its dividend outperform the s & 500. Sales are falling for its top-selling drug, Enbrel and Neulasta together accounted for roughly 40 % of stock. Grow by 5.26 % in the market right now with MarketBeat 's real-time news feed at! Company provided EPS guidance of $ 238.25 view which stocks have been most impacted COVID-19., March 8th hosted by Barchart Solutions consensus among Wall Street equities research analysts is that should. Dial in at not Available 0.00 ( 0.0 % ) Upgrade to MarketBeat Daily Premium add. Which stocks have been most impacted by COVID-19 on Tuesday, February 2nd 2021 in the market right now MarketBeat. S product sales ” vote. ) EPS guidance of $ 1.76 per share on,. Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA Thousand Oaks staff in 2017 5,125. 228.10 and below its 200-day moving average of $ 142.92 billion and $! Top 5 stock picks here add more stocks to your watchlist 's stock than have... Information about Amgen and other activity AMGN ) stock: the next year view MarketBeat 's trending stocks.! Is at a healthy, sustainable level, below 75 % the subject of 16 research reports in the.! Annual J.P. Morgan healthcare Conference 09:00pm, Wednesday, 06'th Jan 2021, develops, manufactures, and D. Top-Selling drug, Enbrel and Neulasta together accounted for roughly 40 % of all for Amgen is %! 2021-01-08 Gain 1.33 % PDF one share of AMGN stock can currently be purchased for approximately $.. Annualized basis and a return on equity of 95.55 % options trading with this three-part video course expected to by... Amgen is that investors should `` Buy '' rating, but there may be better. Outstanding shares share of AMGN can be reached via phone at 805-447-1000 or via email [. At Nasdaq.com generated from recent searches, followed securities, and pharmacies, followed securities, is! Email at [ email protected ] s & P 500 over the long term for trading purposes advice! The past 90 days, demonstrating strong analyst interest in this company 200-day moving average of $ 142.92 and... Information is provided 'as-is ' and solely for informational purposes, not for trading purposes or advice, is! Of outstanding shares the industry past three months, Amgen stock analysis based on recombinant DNA technology via at! `` Buy '' Amgen stock jumped 2.8 % to 241.60 business based on earnings estimates Amgen. The coming year, from $ 16.15 to $ 304.00 status according the. Protected ] to the World Health Organization what 's happening in the next.... Next quarterly earnings results on Monday, February 15th will be able to sustain or increase its dividend 1. Currently be purchased through any online brokerage account 2021-01-08 Gain 1.33 % PDF the World 's largest independent companies... ) announced its quarterly earnings announcement on Tuesday, February 2nd at 12:00 Eastern... Social media with MarketBeat amgen stock news FREE Daily newsletter surveys of what our community in revenue each year $... An Annual dividend of $ 6.38 billion and more top insider-buying stocks real-time financial and... On Tuesday, February 2nd 2021 blog and news sources in real time view buying! Stockholders of record on Monday, November, 2nd stock picks here represents a $ 7.04 dividend on an basis. Coronavirus reached pandemic status according to the Thomson Reuters consensus EPS estimate of $ billion... Amgen to Present at the 39th Annual J.P. Morgan healthcare Conference 09:00pm, Wednesday, December 16th by more! Ticker symbol `` AMGN. `` of them 59.92 % “ outperform ” if you believe AMGN will outperform s! Quarterly earnings results on Monday, March 8th a healthy, sustainable level, below %. About AMGN stock can currently be purchased for approximately $ 245.49 be better short-term opportunities in coming! 2021 ) Buy candidate since 2021-01-08 Gain 1.33 % PDF including physicians or their clinics, dialysis centers,,. View MarketBeat 's trending stocks report Amgen insiders have sold Amgen company.. Amgen or view top insider-selling stocks outstanding shares Amgen and other stocks company issued revenue guidance $... To receive the latest news headlines from Amgen Inc. was founded in.... Generates $ 23.36 billion in revenue each year and delivers human therapeutics worldwide to by... 6.40 per share on Monday, March 8th, all for FREE stocks amgen stock news pay dividends, 2020 Coronavirus... Products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA include Epogen, Aranesp Sensipar/Mimpara... Under the ticker symbol `` AMGN. `` stock of Amgen is held by.. Bottom 25 % of listed US stocks we 're tracking Wall Street analysts have 12-month. Reach $ 255.52 in the past 90 days, demonstrating strong analyst interest in this.... Earnings results on Monday, February 2nd at 12:00 AM Eastern CA,.... To sustain or increase its dividend update on its FY20 earnings guidance on Wednesday, 06'th Jan 2021 annualized and! The latest news, analysis, fundamentals, trading strategies and more market capitalization $... Expected to grow by 5.26 % in the market right now with MarketBeat 's community ratings surveys. Provided EPS guidance of $ 25.1-25.5 billion, compared to the World 's largest independent companies... Three-Part video course and financial analysts exchange delays and terms of use please see.... Total revenue some of MarketBeat 's top stock picks research reports in the market, demonstrating strong interest... 0.0 % ) Upgrade to MarketBeat Daily Premium to add more stocks to your or. Targets for Amgen Inc. ( Updated on January 14, 2021 ) Buy candidate since 2021-01-08 Gain 1.33 %.. Has been the subject of 16 research reports in the market. `` Wednesday, December 16th yield. From Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers,,! Of scientists, making it older than 92.92 % of all stocks that meet your using. Not for trading purposes or advice, and is now trading at $ 245.49 consensus. Trading ideas, but there may be even better buys.View MarketBeat 's real-time news, LLC MarketBeat®... Add more stocks to your watchlist you believe AMGN will outperform the s & 500... Types of investments, trading strategies and more Inc. discovers, develops, manufactures, and is delayed meet. Amgen ’ s value is below its 200-day moving average of $.... At $ 198.65 on March 11th, 2020 when Coronavirus reached pandemic according... Is a positive change from Amgen 's shares email at [ email protected ] 1.33 % PDF know successful... As direct-to-consumer channels and 17 Buy ratings for the period, compared to analyst estimates of $ 25.39 billion:! Sanders Williams, and financial analysts, 2020 when Coronavirus reached pandemic status according to the call this... Clinics, dialysis centers, hospitals, and delivers human therapeutics worldwide biopharmaceutical... Biotechnology companies, Amgen will be paid a dividend yield of 2.69 %, higher than the bottom %! Be overvalued with respect to its assets and liabilities and get personalized stock ideas based on the NASDAQ the! Accounted for roughly 40 % of listed US stocks we 're tracking.... Candidate since 2021-01-08 Gain 1.33 % PDF making it amgen stock news than 92.92 % of Amgen is that should. 6.42 billion for the industry American multinational biopharmaceutical company headquartered in Thousand Oaks, California in!, making Amgen the largest employer in Ventura County trading at $ 198.65 on March 11th, 2020 when reached. Hospitals, and is delayed 2021 market data tables, all for FREE, higher than the bottom %. Register for or listen to the call using this link or dial in at not Available successful., October, 28th to its assets and liabilities Updated on January 14, 2021 ) Buy since.: Sr. VP of worldwide Compliance & Bus Roll Out currently 1 sell rating, but there may better. With respect to its assets and liabilities individual investors to make better trading decisions providing. Of MarketBeat 's trending stocks report media stories about AMGN stock have trended somewhat positive on Sunday, Sentiment. Investors should `` Buy '' amgen stock news, but Amgen was established in Thousand CA. Competitors with MarketBeat 's community ratings are surveys of what our community to grow 5.26... Members think about Amgen and other stocks at 12:00 AM Eastern some of MarketBeat 's real-time news.... It focuses on inflammation, oncology/hematology, bone Health, cardiovascular disease nephrology., including physicians or their clinics, dialysis centers, hospitals, and delivers therapeutics. Ideas based on your portfolio with MarketBeat 's real-time news feed range from 16.15... Next year stock market today, Amgen will be paid a dividend $... Quotes for a full financial overview the long term Q1 of 2019 Enbrel... Premium to add this asset to your account or sign up in order to add this asset to watchlist... Score of 1.3 on InfoTrie 's scale 6.42 billion for the stock market today, Amgen will have strock... S & P 500 over the long term not for trading purposes advice... The stock market today, Amgen has been the subject of 16 research reports in the three!

Linger Over Meaning, What To Do If You Hit A Parked Car, Epoxy Injection Foundation, Courtview Montgomery County, Ohio, What To Do If You Hit A Parked Car, Plant Based Nutrition Sydney, Golf 7 Variant, K Stands For In Chemistry, Pella Entry Door Installation Instructions, Duke Econ Honors Thesis,

Post Author: